Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-12-30
2000-04-18
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 16, 424499, 424 45, 424423, 424430, 424435, 424436, 443451, 443464, A61K 3800
Patent
active
060515589
ABSTRACT:
A liquid composition for the controlled release of gonodotropin releasing hormone (GnRH) or its analogs is provided that includes: (i) a non-polymeric, non-water soluble liquid carrier material (HVLCM) of viscosity of at least 5,000 cP at 37.degree. C. that does not crystallize neat under ambient or physiological conditions; and (ii) GnRH or analogs thereof.
REFERENCES:
patent: 3853837 (1974-12-01), Fujino et al.
patent: 3992365 (1976-11-01), Beddell et al.
patent: 4024248 (1977-05-01), Konig et al.
patent: 4100274 (1978-07-01), Dutta et al.
patent: 4411890 (1983-10-01), Momany
patent: 5352662 (1994-10-01), Brooks et al.
patent: 5391381 (1995-02-01), Wong et al.
patent: 5399363 (1995-03-01), Liversidge et al.
patent: 5487898 (1996-01-01), Lu et al.
patent: 5545408 (1996-08-01), Trigg et al.
patent: 5736152 (1998-04-01), Dunn
patent: 5747058 (1998-05-01), Tipton et al.
patent: 5750100 (1998-05-01), Yamagata et al.
patent: 5840329 (1998-11-01), Bai
Becker, S.E., et al. "Effects of Gonadotropin-Releasing Hormone Infused in a Pulsatile or Continuous Fashion on Serum Gonadotropin Concentrations and Ovulation in the Mare," J. Anim. Sci. (1992) 70:1208-1215.
Buhler, K., GnRH Agonists and Safety, In GnRH Analagoues The State of the Art 1993, A Summary of the 3rd Internaitonal Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneva, Feb. 1993.
Fleury, J., et al. "Evaluation of the Saber.TM. Delivery System for the Controlled Release of the Deslorelin for Advancing Ovulation in the Mare: Effects of Formulation & Dose," Proceed. Int'l Symp. Control. Rel. Bioact. Mater. 25 (1998) Controlled Release Society, Inc. pp. 657-658.
Ginther, O.J., Reproductive Biology of the Mare: Basic and Applied Aspects, EquiServices, Chapter 12, 499-508 Cross Plains, Wisconsin (1970).
Ginther, O.J. et al. "Effect of a Synthetic Gonadotropin-Releasing Hormone on Plasma Concentrations of Luteinizing Hormone in Ponies," Am. J. Vet. Res., 35: 79-81 (1974).
Ginther, O.J., "Ultrasonic Imaging and Reproductive Events in the Mare," Equiservices, Cross Plains, WI Chapter 4: 43-72 (1986).
Hyland, J.H., et al. "Infusion of Gonadotrophin-Releasing Hormone (GnRH) Induces of Ovulation and Fertile Oestrus in Mares During Seasonal Anoestrus," J. Reprod. Fert., Suppl. 35 (1987), 211-220.
Irvine, C.H. G., "GnRH Clinical Application," In Equine Reproduction, (eds) McKinon, A.O. and Voss, J.L., Chapter 36, pp. 41-45, Lea & Febiger (1993).
Irvine, D.S., et al., "Duration of Oestrus and Time of Ovulation in Mares Treated with Synthetic GnRH (Ay24,031)," J. Reprod. Fert. Supp. 23:279-283 (1975).
Jochle, W., et al., Control of Ovulation in the Mare with Ovuplant.TM., a Short-Term Release Implant (STI) Containing the GNRH Analogue Deslorelin Acetate: J. Eq. Vet. Sci., 44:632 (1994).
LaCoste, D., et al., "Reversible Inhibition of Testicular Androgen Secretion by 3-, 5-and 6-Month Controlled-Release Microsphere Formulations of the LH-RH Agonist [D-Trp.sup.6, des-Gly-NH.sub.2.sup.10 ] LH-RH Ethylamide in the Dog," J. Steroid Biochem. 33:5, 1007-1011 (1989).
Loy, R.G. et al. "The Effects of Human Chorionic Gonadotrophin on Ovulation, Length of Estrus, and Fertility in the Mare," Cornell Vet. 56:41-50 (1966).
McCarthy, P.F., et al., "Management of Stallions on Large Breeding Farms," Blanchard, T.K. and Varner, D.D. (eds.) Stallion Management, Vet. Clin. N. Amer. Equine Prac., 8:219-236 (1992).
McKinnon, A.O., et al. "Effect of a GnRH Analogue (Ovuplant), hCG and Dexamethasone on Time to Ovulation in Cycling Mares," World Equine Veterinary Review, (1997) 2:3 16-18.
Mearns, D., "Sires' Live-Foal Percentages in 1996," The Blood Horse, vol. 39, 4794 (1996).
Merrifield, B., Science 232:342 (1986).
Montovan, S.M., et al., "The Effect of a Potent GnRH Agonist on Gonadal and Sexual Activity in the Horse," Theriogenology, 33:6, 1305-1321 (1990).
Nett et al., "Further Studies on the Radioimmunoassay of Gonadotropin-Releasing Hormone: Effect of Radioiodination, Antiserum and Unextracted Serum on Levels of Immunoreactivity in Serum," Endocrinology 101: 1135 (1977).
Rabb et al., "Effects of Active Immunication Against GnRH on LH, FSH and Prolactin Storage, Secretion and Response to Their Secretagogues in Pony Geldings," J. Anim. Sci., 68: 3322-3329 (1990).
Roser, J.J., et al., "The Development of Antibodies to Human Chorionic Gonadotropins Following its Repeated Injection in the Cyclic Mare," J. Reprod. Fert. Suppl., 173-179 (1979).
Sullivan, J., "Duration of Estrus and Ovulation Time in Nonlactating Mares Given Human Chorionic Gonadotropin During Three Successive Estrous Periods," J. Am. Vet. Med. Assoc., 63:895 (1973).
Thompson, Jr., D.L., et al., "Effects of Melatonin and Thyrotropin Releasing Hormone of Mares During the Nonbreeding Season," J. Anim. Sci., 58:3, 668-677(1983).
Thompson, Jr., D.L., et al., "Testosterone Effects on Mares During Synchoronization with Altrenogest: FSH, LH, Estrous, Duration and Pregnancy Rate," J. Anim. Sci., 56: 3, 678-686 (1983).
Voss, J.L., et al. "The Effect of HCG on Duration of Oestrus, Time and Fertility in Mares," J. Reprod. Fert., Suppl. 23 (1975) 297-301.
Burns Patrick J.
Gibson John W.
Tipton Arthur J.
Gray, Esq. Bruce D.
Moezie F. T.
Southern Biosystems, Inc.
LandOfFree
Compositions suitable for controlled release of the hormone GnRH does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions suitable for controlled release of the hormone GnRH, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions suitable for controlled release of the hormone GnRH will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2336418